JAK2 and cancer: We also found similar degrees of early apoptosis between KBV20C cells treated with VIC–fedratinib, VIC–CEP-33779, and VIC–NVP-BSK805, indicating that co-treatment with JAK2 inhibitors can increase cytotoxicity in P-gp overexpressing resistant cancer cells by inducing early apoptosis.